Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1 1

Status

Completed 4

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Other neoplasm 4Breast 4Gastrointestinal 3Head & Neck 2Thoracic 1Sarcoma 1Other solid neoplasm 1Dermatologic 1

Conditions

Breast Neoplasms 4Pain 1Neoplasms 1Inflammation 1Hypertension 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1

Interventions

Trastuzumab 379Paclitaxel 369Cyclophosphamide 338Docetaxel 314Capecitabine 198Doxorubicin 196Letrozole 184Tamoxifen 154Carboplatin 153Fulvestrant 136Bevacizumab 129Anastrozole 120exemestane 119Lapatinib 117Epirubicin 116Gemcitabine 112Radiotherapy 107palbociclib 94Exercise 87Fluorouracil 83Vinorelbine 82Surveys and Questionnaires 81pertuzumab 77Albumin-Bound Paclitaxel 76Filgrastim 71130-nm albumin-bound paclitaxel 64pembrolizumab 63Everolimus 59Cisplatin 59eribulin 58

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Sulindac × Breast × Clear all
NCT04542135 2025-06-03

Sulindac and Breast Density in Women at Risk of Developing Breast Cancer

Stony Brook University

Phase 2 Completed
62 enrolled
Breast

Breast Neoplasms

NCT01761877 2023-02-10

NSAID Effects on Clinical and Imaging Breast Biomarkers

Stony Brook University

Phase 2 Completed
114 enrolled 11 charts
Breast

Breast Neoplasms, Hypertension, Inflammation, Neoplasms, Pain

NCT00039520 2014-05-06

Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer

Fox Chase Cancer Center

Phase 2 Completed
10 enrolled
Breast

Breast Neoplasms

NCT00245024 2013-05-03

Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer

National Cancer Institute (NCI)

Phase 1 Completed
30 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡